Literature DB >> 29066318

5-ALA-Induced Fluorescence in Leptomeningeal Dissemination of Spinal Malignant Glioma.

Zarela Krause Molle1, Kristin Gierga2, Bernd Turowski3, Hans-Jakob Steiger4, Jan Frederick Cornelius4, Marion Rapp4, Michael Sabel4, Marcel A Kamp4.   

Abstract

BACKGROUND: 5-Aminolevulinic acid (5-ALA)-fluorescence-guided resection of malignant glioma is well established in many neuro-oncology departments. In addition, the use of 5-ALA has been reported for cerebral metastases, meningioma, and spinal tumors. We report a case of a patient with a leptomeningeal spread of a K27M-mutated spinal anaplastic astrocytoma (World Health Organization° [WHO] III), which was detected by its faint 5-ALA-induced fluorescence. CASE DESCRIPTION: A 26-year-old female patient with an incomplete resection of a spinal astrocytoma (WHO II) at Th1-Th3 was treated with adjuvant combined radiotherapy/chemotherapy. After 4 years the patient suffered from a progressive paraplegia. Magnetic resonance imaging of the central nervous system showed no local progression of the spinal astrocytoma but an extensive disseminated leptomeningeal tumor formation. The cerebrospinal fluid of the patient obtained by lumbar puncture showed no indication of malignant cells in the cytopathologic examination. An open biopsy with preoperative administered 5-ALA with excision of the sensory nerve root from the cauda equina was performed. The biopsy showed a clearly light pink 5-ALA-induced fluorescence. The histopathologic examination confirmed a leptomeningeal spread of a K27M-mutated anaplastic astrocytoma (WHO° III) without R132H-IDH1 mutation.
CONCLUSIONS: Previous application of 5-ALA might intraoperatively help to visualize and identify leptomeningeal spread.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-ALA; Fluorescence; Leptomeningeal dissemination; Malignant glioma; Metastases; Spinal

Mesh:

Substances:

Year:  2017        PMID: 29066318     DOI: 10.1016/j.wneu.2017.10.069

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

Review 1.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

2.  Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.

Authors:  Johannes Knipps; Igor Fischer; Lisa M Neumann; Marion Rapp; Maxine Dibué-Adjei; Christiane Freiin von Saß; Jan-Malte Placke; Hendrik-Jan Mijderwijk; Hans-Jakob Steiger; Michael Sabel; Jan-Frederick Cornelius; Marcel A Kamp
Journal:  Clin Exp Metastasis       Date:  2019-08-02       Impact factor: 5.150

3.  Sodium Fluorescein for Spinal Intradural Tumors.

Authors:  Semih Kivanc Olguner; Ali Arslan; Vedat Açık; İsmail İstemen; Mehmet Can; Yurdal Gezercan; Ali İhsan Ökten
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

4.  Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.

Authors:  Xun Kang; Feng Chen; Shou-Bo Yang; Ya-Li Wang; Zeng-Hui Qian; Yan Li; Hao Lin; Parker Li; Yi-Chen Peng; Xiao-Min Wang; Wen-Bin Li
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

5.  Fluorescein-guided surgery for intradural spinal tumors: A single-center experience.

Authors:  Salvatore Massimiliano Cardali; Giuseppe Ricciardo; Giada Garufi; Giovanni Raffa; Francesco Messineo; Gianluca Scalia; Alfredo Conti; Antonino Germanò
Journal:  Brain Spine       Date:  2022-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.